Clinical Trials in New York

Showing 13221-13240 of 22,668 trials

Oral Iron for Erythropoietic Protoporphyrias

NCT02979249

In the medical literature there are conflicting reports on whether iron improves symptoms in patients with EPP and XLP. Giving iron to people who are iron deficient is thought to improve EPP symptoms. However, this has never been systematically tested. Therefore, the purpose of this study is to determine the effect of oral iron for EPP and XLP patients.

Erythropoietic ProtoporphyriaEPPX-linked Protoporphyria+1 more

Icahn School of Medicine at Mount Sinai16 participantsStarted Dec 2016

Birmingham, Alabama, United States • San Francisco, California, United States • New York, New York, United States +3 more locations

COMPLETEDPhase 2< 1 mile

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT03160898

The purpose of this study was to assess the effect of CK-2127107 (hereafter referred to as reldesemtiv) versus placebo on respiratory function and other measures of skeletal muscle function in patients with ALS.

Amyotrophic Lateral Sclerosis

Cytokinetics458 participantsStarted Jul 2017

Phoenix, Arizona, United States • Los Angeles, California, United States • Orange, California, United States +61 more locations

Oral Iron for Erythropoietic Protoporphyrias

A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Find Trials by Condition in New York

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

Renal AL Amyloid Involvement and NEOD001

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

A Study of Abemaciclib (LY2835219) in Combination With Another Anti-cancer Drug in Participants With Lung Cancer (NSCLC)

Longitudinal Assessment of Spinal Cord Structural Plasticity Using DTI in SCI Patients

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture

Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain

Randomized Evaluation of Default Access to Palliative Services

Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

Clinical Evaluation of Flortaucipir F 18

Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis

Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)